NDC 65876-0001-3 - Neomycin Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65876-0001
- Requested NDC
- 65876-0001-3
- Package NDCs from labels
- 65876-0001-1, 65876-0001-2, 65876-0001-3, 65876-0001-4
- Manufacturer
- Yichang Sanxia Pharmaceutical Co., Ltd. | Sanxia Pharmaceutical (Hubei Yichang Xiaoting) Co., Ltd.
- Effective date
- 2026-04-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neomycin Sulfate | Yichang Sanxia Pharmaceutical Co., Ltd. | Sanxia Pharmaceutical (Hubei Yichang Xiaoting) Co., Ltd. | 2026-04-13 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65876-0001-1 | Neomycin Sulfate | 25 kg in 1 DRUM | POWDER | 25 | 27 | |
| 65876-0001-2 | Neomycin Sulfate | 20 kg in 1 DRUM | POWDER | 20 | 27 | |
| 65876-0001-3 | Neomycin Sulfate | 23 kg in 1 DRUM | POWDER | 23 | 27 | |
| 65876-0001-4 | Neomycin Sulfate | 30 kg in 1 DRUM | POWDER | 30 | 27 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65876-0001 | NEOMYCIN SULFATE POWDER [YICHANG SANXIA PHARMACEUTICAL CO., LTD.] | 20 | 4 package rows | 20240426_0dd4abe9-60da-45f1-bc95-c65ce954ec20.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Walgreen Company | e2b7fc5b-c796-4ed1-aea7-4c810df250d5 | 2025-07-15 | Warnings | 057Y626693 |
| Publix antibiotic plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Publix Super Markets Inc | d0193bf1-a257-490e-a058-5e6a514981da | 2025-07-15 | Warnings | 057Y626693 |
| Live Better Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | The Great Atlantic & Pacific Tea Company | 7d3435ad-7d73-4db6-8019-3040b3dadfa9 | 2025-07-14 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | Wal-Mart Stores, Inc. | f5199476-1ce2-4a82-9685-40d78b7a8935 | 2025-07-14 | Warnings | 057Y626693 |
| Antibiotic Plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | TARGET Corporation | 6fba5890-f48f-4302-a8ac-5087a6e03bd5 | 2025-07-11 | Warnings | 057Y626693 |
| TopCare Antibiotic Plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Topco Associates LLC | 55dc4025-f07f-41b2-8b18-6a11ee04b5cc | 2025-07-11 | Warnings | 057Y626693 |
| Curad Maximum Strength Triple Antibiotic | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE HYDROCHLORIDE | Medline Industries, LP | 99e9c394-ebf1-7a27-e053-2a95a90ab157 | 2025-07-01 | Warnings | 057Y626693 |
| Triple Antibiotic plus Pain Relief Maximum Strength | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND PRAMOXINE HYDROCHLORIDE | Chain Drug Consortium, LLC | 55ef2205-aaf1-4aa4-917f-2b4cfa43b77e | 2025-07-01 | Warnings | 057Y626693 |
| Meret Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 385d8642-9eae-a750-e063-6394a90a7931 | 2025-06-24 | Warnings | 057Y626693 |
| ProCure Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Twin Med LLC | 37a3916f-cc1a-41a0-e063-6394a90a35ed | 2025-06-16 | Warnings | 057Y626693 |
| SionBiotext Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Sion Biotext Medical Ltd | 35083d42-5823-eeb1-e063-6294a90acafa | 2025-05-13 | Warnings | 057Y626693 |
| Multi Action | BACITRACINZINC,NEOMYCINSULFATE,POLYMYXINBSULFATE,PRAMOXINEHCL | Trifecta Pharmaceutical USA LLC | b98082f3-be95-49fb-e053-2a95a90a37b8 | 2025-05-13 | Warnings | 057Y626693 |
| Leader Triple antibiotic and pain relief | BACITRACIN,NEOMYCIN,POLYMXIN, PRAMOXINE | Cardinal Health 110 dba LEADER | f4c521d9-dd05-1c23-e053-2995a90a6e2c | 2025-05-13 | Warnings | 057Y626693 |
| Tripleantibioticointmentandpainrelief | BACITRACIN,NEOMYCIN,POLYMXIN, PRAMOXINE | Trifecta Pharmaceuticals USA | 34f1db74-6506-d53d-e063-6394a90ac400 | 2025-05-12 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Bausch & Lomb Incorporated | b0ee85dd-5fe1-46a3-9bff-606e489d20b1 | 2025-04-30 | Warnings, Adverse reactions | 057Y626693 |
| Triple Antibiotic plus Lidocaine | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE, LIDOCAINE | TRIFECTA PHARMACEUTICALS USA LLC | 14fda967-54ba-c964-e063-6294a90a21ee | 2025-04-24 | Warnings | 057Y626693 |
| NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE SUSPENSION/ DROPS | DirectRx | d5e00bad-abb4-63ad-e053-2a95a90a5abb | 2025-04-15 | Warnings, Adverse reactions | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | Front Pharmaceutical PLC | 3244d91e-6c6b-a351-e063-6294a90aa02d | 2025-04-08 | Warnings | 057Y626693 |
| Redicare Triple Antibiotic First Aid | TRIPLE ANTIBIOTIC FIRST AID OINTMENT | Redicare LLC | 9468979d-446e-e4be-e053-2995a90a3f21 | 2025-03-05 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc. | cf1a6da8-ba79-4bff-a13b-6effb67f6c1c | 2025-02-20 | Warnings, Adverse reactions | 057Y626693 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.